Safety and efficacy of Emtricitabine/rilpivirine/tenofovir-disoproxil-fumarate (Eviplera) as a switch treatment option in HIV infected patients.
Phase of Trial: Phase IV
Latest Information Update: 07 Dec 2015
At a glance
- Drugs Emtricitabine/rilpivirine/tenofovir disoproxil fumarate (Primary)
- Indications HIV infections
- Focus Adverse reactions; Therapeutic Use
- 07 Dec 2015 New trial record